someone here previously mentioned that since this trial is open label that the data would be more generally accessible throughout the process.

Quote:

---

That data is generally known only to the DMSB because if the sponsor of the trial or CRO knows the data it could influence the trial. However with very promising data the company will sometimes request its release to them.

---